UAB Researchers Use CRISPR Technology to Target Childhood Syndrome
In the last couple of years there’s been a bonanza in life sciences around something called CRISPR. This is a process that bacteria do naturally as a defense mechanism, but scientists have figured out how to use it to snip out specific genes from DNA and replace them. In other words, it makes cheaper and more precise genetic editing possible.
“This kind of CRISPR technology that many people are practicing now is going to change the whole field of medicine,” says Tim Townes, director of the UAB Stem Cell Institute.
Townes led a team that published a paper Thursday in Cell Reports on their use of CRISPR to develop a potential new cure for a troubling condition in children. It’s called severe combined immunodeficiency or SCID. Children born with SCID have no immune response so they can’t fight invading viruses or bacteria. It’s more popularly know as the “bubble boy” syndrome. The only current treatment is a bone marrow transplant. Otherwise SCID is fatal.
Townes received skin cells from a patient who was successfully cured through a bone marrow transplant. His team then changed those cells to stem cells and used the CRISPR technique to change the one DNA base pair that causes SCID. The idea is that those cells would then be converted to blood stem cells and transplanted back into the patient, curing him or her.
“So they would be getting their own cells. But those cells would be corrected,” said Townes.
The Food and Drug Administration hasn’t allowed any studies on people using CRISPR yet, but Townes expects UAB to start clinical trials on the SCID therapy within two years.
While CRISPR has the potential to revolutionize biology, from curing genetic diseases to creating mosquitos that can’t carry malaria, it comes with weighty ethical concerns. Scientists and bioethicists are already warning about unintended consequences from changed genes, particularly if they are passed on to children. Also, CRISPR could theoretically be used to by parents to create “designer babies,” genetically engineered for desirable traits.
Scientists in China prompted an uproar earlier this year when they announced they used CRISPR to alter genes in human embryos.
Townes said they check carefully they only change the base pair targeted. He also says they’re only interested in curing disease.
“Any technology can be used for good or not so good purposes,” said Townes. “We want to develop new technology and it’s up to society as a whole to apply them in the correct way.”
Extra: Radiolab explains CRISPR
Trump names former Florida AG Pam Bondi as his new pick for U.S. attorney general
After former Rep. Matt Gaetz withdrew from consideration, President-elect Donald Trump named Pam Bondi, a former attorney general of Florida, as his next pick for U.S. attorney general.
Police report gives details, timeline of the sexual assault claim against Pete Hegseth
The woman who accused then-Fox News host of sexual assault in 2017 said that she "remembered saying 'no' a lot," according to a police report. Hegseth is President-elect Donald Trump's choice for Secretary of Defense.
Alabama Black Belt’s sewer crisis a tougher fix for residents in manufactured homes
Poor sanitation has long plagued residents in Alabama’s Black Belt. For people with manufactured houses, finding a solution has been more challenging.
In Birmingham, Black men’s groups work to save young men from the cycle of gun violence
As the city inches closer to its homicide record, community members are trying to address a sense of fatalism and lack of opportunity felt by some young men.
What is the ICC and can it really arrest Israeli Prime Minister Benjamin Netanyahu?
The ICC also issued warrants for Yoav Gallant, former Israeli defense minister, and Hamas leader Muhammad Deif. But it doesn't have an enforcement mechanism and relies on states to make the arrests.
Former Brazilian president indicted over alleged coup plot
Brazil's former President Jair Bolsonaro and several others have been charged with attempting to overthrow incoming government of President Luiz Inácio Lula da Silva in 2022.
